Physicochemical Properties
| Molecular Formula | C16H28CLN3O4 |
| Molecular Weight | 361.8642 |
| Exact Mass | 361.176 |
| CAS # | 1208862-61-6 |
| Related CAS # | H-Ile-Pro-Pro-OH;26001-32-1 |
| PubChem CID | 146673017 |
| Appearance | Off-white to light yellow solid powder |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Heavy Atom Count | 24 |
| Complexity | 482 |
| Defined Atom Stereocenter Count | 4 |
| SMILES | Cl[H].O=C([C@]1([H])C([H])([H])C([H])([H])C([H])([H])N1C([C@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])N([H])[H])=O)N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(=O)O[H] |
| InChi Key | XRXZJOQURIUXLP-KRBYAKJKSA-N |
| InChi Code | InChI=1S/C16H27N3O4.ClH/c1-3-10(2)13(17)15(21)18-8-4-6-11(18)14(20)19-9-5-7-12(19)16(22)23;/h10-13H,3-9,17H2,1-2H3,(H,22,23);1H/t10-,11-,12-,13-;/m0./s1 |
| Chemical Name | (2S)-1-[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | IC50: 5 μM (ACE)[2] |
| ln Vitro | Ile-Pro-Pro (IPP; 1 nM, 0.1 μM, and 10 μM) stimulates human umbilical vein endothelial cells (HUVECs) to produce more nitric oxide (NO)[1]. |
| ln Vivo | In rats treated with L-NAME, Ile-Pro-Pro (IPP; 30 mg/kg daily; 0.3 g/L) attenuates vascular dysfunction[1]. In spontaneously hypertensive rats (SHR), Ile-Pro-Pro lowers blood pressure [1]. Apolipoprotein E-deficient (apoE(-/-)) mice show reduced development of atherosclerosis when exposed to Ile-Pro-Pro[1]. |
| References |
[1]. The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats. Hypertens Res. 2014 Aug;37(8):703-7. [2]. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci. 1995 Apr;78(4):777-83. |
Solubility Data
| Solubility (In Vitro) |
H2O: 55 mg/mL (151.99 mM) DMSO: 36.67 mg/mL (101.34 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.75 mg/mL (7.60 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.75 mg/mL (7.60 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.75 mg/mL (7.60 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 100 mg/mL (276.35 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7635 mL | 13.8175 mL | 27.6350 mL | |
| 5 mM | 0.5527 mL | 2.7635 mL | 5.5270 mL | |
| 10 mM | 0.2764 mL | 1.3817 mL | 2.7635 mL |